Day: June 1, 2020

SOUTH SAN FRANCISCO, Calif., June 01, 2020 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), today announced the commencement of an underwritten public offering of $450.0 million of shares of its common stock. In addition, Allogene expects to grant the underwriters a 30-day option to purchase up to an additional $67.5 million of shares of its common stock offered in the public offering. All of the shares of common stock to be sold in the offering will be sold by Allogene. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.The securities described above are being offered by Allogene pursuant to a shelf registration statement (including a prospectus) filed on November 5, 2019 with the Securities...

VANCOUVER, Washington, June 01, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, Jacob Lalezari, M.D., CEO of Quest Clinical Research and Chief Science Officer of CytoDyn, along with a representative of Amarex Clinical Research, the Company’s CRO, will provide a comprehensive business and clinical trials update.  The Wall Street Reporter’s event is scheduled for Tuesday, June 2, 2020 at 12:30 pm ET / 9:30 am PT. The presentation will be approximately 15-20 minutes followed by a Q&A session of approximately 30-40 minutes.Interested participants are encouraged...

VIRGINIA BEACH, Va., June 01, 2020 (GLOBE NEWSWIRE) — Armada Hoffler Properties, Inc. (NYSE: AHH) announced today that it has completed the sale of a portfolio of retail assets to an institutional buyer for $90 million. The transaction included seven shopping centers totaling over 630,000 square feet, or 15% of the Company’s retail portfolio.“With the completion of this portfolio sale, we accomplish a number of short and long-term objectives,” said Louis Haddad, President & CEO of Armada Hoffler Properties. “In addition to considerably reducing the percentage of retail assets in our portfolio, the proceeds from this sale of unencumbered properties allow us to enhance our liquidity position and create further balance sheet flexibility. More importantly, this transaction represents a significant step toward achieving our longer-term...

LOS ANGELES, June 01, 2020 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies 2020 Virtual Global Healthcare Conference on Tuesday, June 2, 2020 at 1:30 p.m. Eastern Time. There will be simultaneous and archived webcasts available at http://wsw.com/webcast/jeff126/rdnt/ and www.radnet.com under the “About RadNet” menu section and “News and Press Releases” sub-menu of the website.About RadNet, Inc. RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of...

ST. JOHN’S, Newfoundland, June 01, 2020 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF), Canada’s Ocean Company, announced it has filed its financial results for the quarter ended March 31, 2020. Additional information concerning the Company, including its consolidated financial statements and related management’s discussion and analysis (“MD&A”) for the quarter ended March 31, 2020, can be found at www.sedar.com. Unless otherwise stated, all dollar amounts are Canadian dollar denominated.  Q1 2020 Financial HighlightsRevenue for the quarter was $6.4 million compared to $1.4 million in the year ago quarter. Revenue in the quarter was driven by the delivery of a KATFISH™ 180 system, additional subsea batteries to a military customer, acoustic signal processing software for a defense contractor as well as Robotics...

TORONTO, June 01, 2020 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX:YRI; NYSE:AUY) (“Yamana” or the “Company”) confirms that a National Instrument 43-101 technical report for the Jacobina gold mine in Brazil, called ‘NI 43-101 Technical Report, Jacobina Gold Mine, Bahia State, Brazil’, with an effective date of December 31, 2019, has been filed with Canadian securities regulators and is now available under Yamana’s profile on www.sedar.com.  The new technical report is also available on the Company’s website www.yamana.com.  The Jacobina gold mine is a long life, low cost mine with estimated current production of 170,000 ounces per year which would increase to an average of 230,000 ounces per year pursuant to a low capital cost expansion, all as more fully described in the NI 43-101 report.About YamanaYamana Gold Inc. is a Canadian-based...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESBrief update on permitting and exploration programsVANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) —  NuLegacy Gold Corporation (“NuLegacy” or the “Company”) (TSXV: NUG; OTCQB: NULG.F) reports that it has completed its previously announced non-brokered private placement of 75,000,000 units (the “Units”) at a price of C$0.075 per Unit to raise gross proceeds to the Company of C$5.625 million (the “Offering”).NuLegacy’s CEO Albert Matter comments that, “We want to thank our new shareholders and many of our existing shareholders who once again stepped up to provide the capital to continue this 10-year adventure of elephant hunting in Nevada. Together with our current cash position, net of issue expenses, we have...

8.35 g/t Au over 6.00 m, approx 300 m east of the 36E Zone, an area largely untested below 400 m13.86 g/t Au over 2.10 m at the western margin of resources in the F ZoneROUYN-NORANDA, Quebec, June 01, 2020 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (TSX-V: RDS, OTC: RMRDF): (“Radisson” or the “Company”) is pleased to announce significant high-grade gold intercepts from the ongoing 60,000 m exploration drill program at its O’Brien gold project located along the Larder Lake Cadillac Break halfway between Rouyn-Noranda and Val-d’Or in Quebec, Canada (See figure 1 and 2). As announced previously, the program resumed on May 11th, after having paused on March 24th, in response to Government of Quebec orders related to the COVID-19 pandemic.“Drilling at O’Brien has continued to deliver excellent results. The initial part of...

8,35 g/t Au sur 6,00 m, 300 m à l’est de la zone 36E, dans un secteur sous exploré dessous 400 m13,86 g/t Au sur 2,10 m sur la frontière ouest des ressources de la Zone FROUYN-NORANDA, Québec, 01 juin 2020 (GLOBE NEWSWIRE) — Ressources minières Radisson Inc. (TSXV: RDS) (« Radisson » ou la « Société ») est heureuse d’annoncer aujourd’hui des résultats significatifs à haute teneur en or de la campagne de forage d’exploration de 60 000 m en cours au projet aurifère O’Brien. Le projet O’Brien se situe le long de la faille Larder-Lake-Cadillac, à mi-chemin entre les deux villes de Rouyn-Noranda et Val-d’Or au Québec. Tel qu’annoncé, le programme de forage a repris le 11 mai 2020, après une pause annoncée le 24 mars 2020 en réponse aux ordres du Gouvernement du Québec liés à la pandémie COVID-19 (Voir figure 1 and 2).« Les forages à...

NEW YORK, June 01, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that treatment with its lead mesenchymal stem cell (MSC) product candidate remestemcel-L in patients with chronic obstructive pulmonary disease (COPD) and an elevated state of inflammation resulted in improved respiratory and functional outcomes. The results were presented as a virtual oral presentation delivered to the 2020 International Society for Cell & Gene Therapy (ISCT) annual meeting held May 28-29, 2020.   The post-hoc analysis from a randomized, placebo-controlled 60-patient Phase 2 trial in patients with COPD showed that remestemcel-L, given in four monthly intravenous doses of 100 million cells, significantly improved respiratory and functional...